The Key Role of Pharmacists Supporting the Landmark Changes in Asthma Management
Take this complimentary CE course and learn how you can educate and empower your patients in this transition from two asthma experts in Canada.
$0.00
Description
Description:
Pharmacists play a crucial role in supporting asthma control therapy in their patients. The Global Initiative for Asthma (GINA) recommends patients receive symptom-driven prescriptions (in mild asthma) or use a daily corticosteroid-containing inhaler, to reduce the risk of severe exacerbations.
How do pharmacists continue to support and help patients navigate asthma control and management?
Take this complimentary CE course and learn how you can educate and empower your patients in this transition from two asthma experts in Canada: Dr. Anne Ellis (Professor in the Department of Medicine at Queen’s University), and Ms. Dorothy Pardalis (Clinical Pharmacist at Tilbury District Family Health Team).
Learning Objectives:
By the end of this course, you should be able to:
- Describe the global and Canadian recommendations to help minimize over-use of short-acting beta-agonists as monotherapy and optimize controller therapy
- Assess the level of control of an asthma patient
- Identify opportunities in the pharmacy to optimize asthma control for their patients
- List common drug therapy problems in patients with asthma that may lead to increased risk of exacerbations
- Apply strategies using the GINA and CTS recommendations to effectively assess, intervene, and partner with patients and their healthcare providers to improve asthma care
Course Outline:
-
Learning Modules (1 hour)Module 1: Landmark Changes in Asthma Management Module 2: The Key Role of Pharmacists
-
Multiple Choice Exam
-
Program Evaluation
Sponsor:
The development of this course is made possible through an educational grant from AstraZeneca.
Course at a glance:
- 1.25 hour to complete
- 1.25 CEUs
- Course expiry date: November 20, 2024
- Online
- Accreditation: 8003-2020-3066-I-P
- Completion requirement: Complete the online modules, multiple-choice exam (with a score of 70 per cent or higher) and the program evaluation before the expiry date to receive a letter of completion.
Who Should Take This Course:
There is no prerequisite to register for this program. This program supports pharmacists interested in Asthma therapy for patients and/or who want to enhance their knowledge and expertise in pharmacy practice.
Development Team:
- Dr. Anne K. Ellis, MD MSc FRCPC
- Dorothy Pardalis BSc. Phm., CRE, CDE
- Lawrence Jackson, RPh (BSc Phm)
- Andrea White Markham, RRT, CRE, CTE
Cancelation Policy:
Please refer to OPA’s Terms and Conditions of Purchase for cancellation policies.
OPA programs you may also like
-
- Sale!
- Alberta Pharmacists’ Association: Board Certified Geriatric Pharmacist (BCGP) Preparation Course
-
$1,400.00$800.00